Physician profile
Mirza Haider Ali
NPI 1467878777
$15,838.63
in general payments reported to CMS, 2019-2025
37 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.75 · 2021: $498 · 2022: $621 · 2023: $2,860 · 2024: $1,553 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,239 · Education: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,820.15 |
| Travel and Lodging | $2,239.33 |
| Education | $1,614.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $5,606.73 | 2022-2025 | Smartvest |
| Astrazeneca Pharmaceuticals Lp | $3,716.32 | 2020-2025 | Breztri, Fasenra, Tezspire |
| Intuitive Surgical, INC. | $2,455.35 | 2025 | |
| Insmed, INC. | $651.63 | 2022-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $496.89 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Amgen INC. | $420.44 | 2021-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $296.06 | 2022-2025 | Dupixent |
| Grifols USA, LLC | $286.50 | 2023-2025 | Prolastin-C Liquid |
| Medtronic, INC. | $171.87 | 2023 | Illumisite |
| Actelion Pharmaceuticals US, INC. | $171.48 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols Shared Services North America, INC. | $159.38 | 2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $158.62 | 2022-2025 | Glassia |
| Merck Sharp & Dohme LLC | $124.97 | 2023-2025 | Winrevair |
| Ethicon INC. | $118.31 | 2024 | Monarch Platform |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.98 | 2021-2025 | Jascayd, Ofev |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $97.58 | 2021 | |
| Genzyme Corporation | $84.43 | 2022-2024 | |
| Verona Pharma, INC. | $83.32 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $82.89 | 2025 | Yupelri |
| United Therapeutics Corporation | $76.22 | 2021-2025 | Tyvaso, Tyvaso |
| Abbvie INC. | $65.55 | 2025 | |
| Mylan Specialty L.P. | $63.01 | 2021-2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $44.73 | 2024 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $43.83 | 2022-2023 | Airduo Digihaler |
| Philips North America LLC | $35.18 | 2022-2024 | (Ak6) Vest Therapy |
| Bayer Healthcare Pharmaceuticals INC. | $25.18 | 2025 | |
| Vifor Pharma, INC. | $24.22 | 2024 | Zemaira |
| Pfizer INC. | $20.02 | 2025 | |
| Baxter Healthcare | $19.98 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $19.11 | 2022 | |
| Phadia US INC. | $18.98 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.11 | 2024 | Nuzyra |
| Medical Device Business Services, INC. | $17.75 | 2025 | Monarch |
| Circassia INC. | $16.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.03 | 2020 | |
| Inogen, INC. | $14.73 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inari Medical, INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirza Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.